New Zealand markets closed

Healthpeak Properties, Inc. (DOC)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
18.97+0.10 (+0.53%)
At close: 04:00PM EDT
19.18 +0.21 (+1.11%)
After hours: 06:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.35B
Enterprise value 22.31B
Trailing P/E 54.20
Forward P/E 105.26
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.70
Price/book (mrq)1.50
Enterprise value/revenue 9.86
Enterprise value/EBITDA 18.48

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-9.66%
S&P500 52-week change 322.38%
52-week high 322.38
52-week low 315.24
50-day moving average 317.88
200-day moving average 318.62

Share statistics

Avg vol (3-month) 37.93M
Avg vol (10-day) 36.29M
Shares outstanding 5703.78M
Implied shares outstanding 6703.78M
Float 8700.11M
% held by insiders 10.31%
% held by institutions 179.02%
Shares short (15 Apr 2024) 410.62M
Short ratio (15 Apr 2024) 41.71
Short % of float (15 Apr 2024) 41.91%
Short % of shares outstanding (15 Apr 2024) 41.51%
Shares short (prior month 15 Mar 2024) 49.7M

Dividends & splits

Forward annual dividend rate 41.2
Forward annual dividend yield 46.33%
Trailing annual dividend rate 31.20
Trailing annual dividend yield 36.36%
5-year average dividend yield 44.93
Payout ratio 4342.86%
Dividend date 317 May 2024
Ex-dividend date 403 May 2024
Last split factor 21098:1000
Last split date 301 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 8.56%
Operating margin (ttm)3.78%

Management effectiveness

Return on assets (ttm)1.22%
Return on equity (ttm)2.51%

Income statement

Revenue (ttm)2.26B
Revenue per share (ttm)4.03
Quarterly revenue growth (yoy)15.40%
Gross profit (ttm)N/A
EBITDA 1.12B
Net income avi to common (ttm)193.06M
Diluted EPS (ttm)0.35
Quarterly earnings growth (yoy)-94.40%

Balance sheet

Total cash (mrq)149.2M
Total cash per share (mrq)0.21
Total debt (mrq)9.06B
Total debt/equity (mrq)94.41%
Current ratio (mrq)2.25
Book value per share (mrq)12.62

Cash flow statement

Operating cash flow (ttm)934.88M
Levered free cash flow (ttm)617.34M